SCI Abstract

search
+
Talazoparib plus enzalutamide versus olaparib plus abiraterone acetate and niraparib plus abiraterone acetate for metastatic castration-resistant prostate cancer: a matching-adjusted indirect comparison
Talazoparib plus enzalutamide versus olaparib plus abiraterone acetate and niraparib plus abiraterone acetate for metastatic castration-resistant prostate cancer: a matching-adjusted indirect comparison
Without head-to-head trials between talazoparib+enzalutamide (TALA + ENZA), olaparib+abiraterone acetate (OLAP...
Radical prostatectomy without prostate biopsy based on a noninvasive diagnostic strategy: a prospective single-center study
Radical prostatectomy without prostate biopsy based on a noninvasive diagnostic strategy: a prospective single-center study
Prostate biopsy is the most common approach for diagnosing prostate cancer (PCa); however, it has inherent limitations, su...
Evaluation of the safety and efficacy of stereotactic body radiotherapy for radio-recurrent prostate cancer: a systematic review and meta-analysis
Evaluation of the safety and efficacy of stereotactic body radiotherapy for radio-recurrent prostate cancer: a systematic review and meta-analysis
Stereotactic body radiotherapy (SBRT) is pivotal in managing radio-recurrent prostate cancer (PCa). This study aims to com...
Survival outcomes of apalutamide as a starting treatment: impact in real-world patients with metastatic hormone sensitive prostate cancer (OASIS)
Survival outcomes of apalutamide as a starting treatment: impact in real-world patients with metastatic hormone sensitive prostate cancer (OASIS)
Androgen receptor pathway inhibitors (apalutamide [APA], enzalutamide [ENZ], abiraterone acetate plus prednisone [AAP]) co...
Advances in ferroptosis for castration-resistant prostate cancer treatment: novel drug targets and combination therapy strategies
Advances in ferroptosis for castration-resistant prostate cancer treatment: novel drug targets and combination therapy strategies
Metastatic prostate cancer (PCa) has much lower survival and ultimately develops castration resistance, which expects nove...
Infectious complications following transperineal prostate biopsy with or without periprocedural antibiotic prophylaxis—a systematic review including meta-analysis of all comparative studies
Infectious complications following transperineal prostate biopsy with or without periprocedural antibiotic prophylaxis—a systematic review including meta-analysis of all comparative studies
Despite the relatively low infection rate following transperineal prostate biopsy (TPB), it remains unresolved whether per...
Negative PSMA PET can be used to avoid unnecessary pelvic lymph node dissection in intermediate risk prostate cancer
Negative PSMA PET can be used to avoid unnecessary pelvic lymph node dissection in intermediate risk prostate cancer
Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) has a high negative predictive value (NPV) in...
Prostate MRI and clinicopathologic risk calculator to predict laterality of extraprostatic extension at radical prostatectomy
Prostate MRI and clinicopathologic risk calculator to predict laterality of extraprostatic extension at radical prostatectomy
Traditional nomograms can inform the presence of extraprostatic extension (EPE) but not laterality, which remains importan...
The changing face of castrate resistant prostate cancer
Petrylak DP, Tangen CM, Hussain MH, Lara PN Jr, Jones JA, Taplin ME, et al. Docetaxel and estramustine compared with mitox...
Trends in pre-biopsy MRI usage for prostate cancer detection, 2007–2022
Trends in pre-biopsy MRI usage for prostate cancer detection, 2007–2022
Clinical guidelines favor MRI before prostate biopsy due to proven benefits. However, adoption patterns across the US are ...
The appropriateness of PSMA PET/CT in newly diagnosed unfavorable intermediate-risk prostate cancer patients—towards a tumor volume-based risk stratification
This study reassesses the diagnostic value of PSMA PET/CT in unfavorable intermediate-risk prostate cancer (PCa) and valid...
Evaluating 4Kscore’s role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS score
Evaluating 4Kscore’s role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS score
4Kscore is used to aid the decision for prostate biopsy, however its role in active surveillance (AS) has not been investi...
Therapeutic implications of homologous repair deficiency testing in patients with prostate cancer (Part 2 of 2)
Unfortunately, not all metastatic castration-resistant prostate cancer (mCRPC) patients receive available life-prolonging ...
Prostate cancer in low- and middle-income countries - challenges and opportunities
James ND, Tannock I, N’Dow J, Feng F, Gillessen S, Ali SA, et al. The Lancet Commission on prostate cancer: planning for t...
Germline and somatic testing for homologous repair deficiency in patients with prostate cancer (part 1 of 2)
Germline and somatic testing for homologous repair deficiency in patients with prostate cancer (part 1 of 2)
Unfortunately, not all metastatic castration resistant prostate cancer (mCRPC) patients receive available life-prolonging ...
Surveillance after Focal Therapy – a Comprehensive Review
Surveillance after Focal Therapy – a Comprehensive Review
to date, no standardized, evidence-based follow-up schemes exist for the monitoring of patients who underwent focal therap...
Incidence and management of BPH surgery-related urethral stricture: results from a large U.S. database
Incidence and management of BPH surgery-related urethral stricture: results from a large U.S. database
Urethral stricture (US) is a well-known complication after surgical treatment of benign prostatic hyperplasia (BPH). This ...
Baseline serum testosterone and differential efficacy of bipolar androgen therapy and enzalutamide in the randomized TRANSFORMER trial
Baseline serum testosterone and differential efficacy of bipolar androgen therapy and enzalutamide in the randomized TRANSFORMER trial
Bipolar androgen therapy (BAT) is effective in a subset of metastatic castration-resistant prostate cancer (mCRPC) patient...
Accuracy, readability, and understandability of large language models for prostate cancer information to the public
Accuracy, readability, and understandability of large language models for prostate cancer information to the public
Generative Pretrained Model (GPT) chatbots have gained popularity since the public release of ChatGPT. Studies have evalua...
Letter to the editor: “Incidence of prostate cancer in transgender women in the US: a large database analysis.”
The opinions expressed by the authors are their own and this material should not be interpreted as representing the offici...
The need for precision medicine in managing cardiovascular risk for men receiving ADT
Competing interests AWH reports advisory board consulting for Johnson & John...
Correction: Real-world four-year functional and surgical outcomes of Rezum therapy in younger versus elderly men
Authors and AffiliationsAlbert Einstein College of Medicine, Bronx, NY, USAMichael Zhu, Mustufa Babar, Noah Hawks-Ladds, M...
A systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET/CT in the initial staging of prostate cancer
A systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET/CT in the initial staging of prostate cancer
Positron Emission Tomography-Computed Tomography using Prostate-Specific Membrane Antigen (PSMA PET/CT) is notable for its...
Risk calculators for the detection of prostate cancer: a systematic review
Risk calculators for the detection of prostate cancer: a systematic review
Prostate cancer (PCa) (early) detection poses significant challenges, including unnecessary testing and the risk of potent...
Correction: Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthcare claims and utilization study
The article Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthca...
The effects of glycemic index on prostate cancer progression in a xenograft mouse model
The effects of glycemic index on prostate cancer progression in a xenograft mouse model
Previously, we found low-carbohydrate diets slowed prostate cancer (PC) growth and increased survival vs. a Western diet i...
High-risk biochemical recurrence of locally treated prostate cancer after EMBARK. An end to decades of conventional wisdom?
Managing biochemical recurrence (BCR) of localized prostate cancers (PCa) that have failed all option...
Real-world prevalence of homologous recombination repair mutations in advanced prostate cancer: an analysis of two clinico-genomic databases
Real-world prevalence of homologous recombination repair mutations in advanced prostate cancer: an analysis of two clinico-genomic databases
Homologous recombination repair mutation (HRRm) status may guide risk-stratification and treatment decisions, including po...
Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer
Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer
Identification of emerging molecular biomarkers on circulating tumor cells (CTCs) represents an attractive feature of liqu...
Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: a retrospective cohort study
Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: a retrospective cohort study
While the cardiovascular risks of androgen receptor pathway inhibitors have been studied, they were seldom compared direct...
Load More
format_indent_increase